Gene · 9376
Papers2,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of a new MDCKII-MDR1 cell model to measure the extent of drug distribution in vitro at equilibrium for prediction of in vivo unbound brain-to-plasma drug distribution. | Fluids Barriers CNS | 2024 | 38273301 | PubTator, text mining | PubMed |
| Comprehensive review of dibenzocyclooctadiene lignans from the Schisandra genus: anticancer potential, mechanistic insights and future prospects in oncology. | Chin Med | 2024 | 38267965 | PubTator, text mining | PubMed |
| Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapy. | JAC Antimicrob Resist | 2024 | 38259903 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor. | Pharmaceuticals (Basel) | 2024 | 38256953 | PubTator, text mining | PubMed |
| New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections. | Antibiotics (Basel) | 2024 | 38247617 | PubTator, text mining | PubMed |
| Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout. | Dis Markers | 2024 | 38222853 | PubTator, text mining | PubMed |
| Relieving urinary tract obstructions may increase the risk of gouty arthritis in patients with hyperuricemia and postrenal obstructions. | Medicine (Baltimore) | 2024 | 38215123 | PubTator, text mining | PubMed |
| Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier. | Fluids Barriers CNS | 2024 | 38200564 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir. | Clin Pharmacokinet | 2024 | 38177893 | PubTator, text mining | PubMed |
| Identification of three distinct cell populations for urate excretion in human kidneys. | J Physiol Sci | 2024 | 38166558 | PubTator, text mining | PubMed |
| Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38156758 | PubTator, text mining | PubMed |
| Maribavir: Mechanism of action, clinical, and translational science. | Clin Transl Sci | 2024 | 38071422 | PubTator, text mining | PubMed |
| Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters. | J Antimicrob Chemother | 2024 | 37995258 | PubTator, text mining | PubMed |
The Effect of BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open-Label, Non-randomized, 2-Period Fixed-Sequence Trial in Healthy Subjects. | Clin Pharmacol Drug Dev | 2024 | 37960990 | PubTator, text mining | PubMed |
| Predicting complex kidney drug handling using a physiologically-based pharmacokinetic model informed by biomarker-estimated secretory clearance and blood flow. | Clin Transl Sci | 2024 | 37921258 | PubTator, text mining | PubMed |
| Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry. | Lancet Infect Dis | 2024 | 37883984 | PubTator, text mining | PubMed |
| Bidirectional pharmacokinetic drug interactions between olaparib and metformin. | Cancer Chemother Pharmacol | 2024 | 37815561 | PubTator, text mining | PubMed |
| Inhibitory interaction of flavonoids with organic anion transporter 3 and their structure-activity relationships for predicting nephroprotective effects. | J Asian Nat Prod Res | 2024 | 37589480 | PubTator, text mining | PubMed |
| Role of metabolomic profile as a potential marker to discriminate membranous nephropathy from IgA nephropathy. | Int Urol Nephrol | 2024 | 37452988 | PubTator, text mining | PubMed |
| Ligand- and Structure-based Approaches for Transmembrane Transporter Modeling. | Curr Drug Res Rev | 2024 | 37157206 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9376/papers?page=7